Works by Ansell, Jack


Results: 79
    1
    2
    3
    4

    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

    Published in:
    European Heart Journal, 2017, v. 38, n. 12, p. 860, doi. 10.1093/eurheartj/ehw069
    By:
    • Diener, Hans-Christoph;
    • Aisenberg, James;
    • Ansell, Jack;
    • Atar, Dan;
    • Breithardt, Günter;
    • Eikelboom, John;
    • Ezekowitz, Michael D.;
    • Granger, Christopher B.;
    • Halperin, Jonathan L.;
    • Hohnloser, Stefan H.;
    • Hylek, Elaine M.;
    • Kirchhof, Paulus;
    • Lane, Deirdre A.;
    • Verheugt, FreekW.A.;
    • Veltkamp, Roland;
    • Lip, Gregory Y. H.
    Publication type:
    Article
    5

    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

    Published in:
    European Heart Journal, 2017, v. 38, n. 12, p. 852, doi. 10.1093/eurheartj/ehv643
    By:
    • Diener, Hans-Christoph;
    • Aisenberg, James;
    • Ansell, Jack;
    • Atar, Dan;
    • Breithardt, Günter;
    • Eikelboom, John;
    • Ezekowitz, Michael D.;
    • Granger, Christopher B.;
    • Halperin, Jonathan L.;
    • Hohnloser, Stefan H.;
    • Hylek, Elaine M.;
    • Kirchhof, Paulus;
    • Lane, Deirdre A.;
    • Verheugt, FreekW.A.;
    • Veltkamp, Roland;
    • Lip, Gregory Y. H.
    Publication type:
    Article
    6
    7

    Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.

    Published in:
    European Heart Journal, 2015, v. 36, n. 20, p. 1264, doi. 10.1093/eurheartj/ehu463
    By:
    • Held, Claes;
    • Hylek, Elaine M.;
    • Alexander, John H.;
    • Hanna, Michael;
    • Lopes, Renato D.;
    • Wojdyla, Daniel M.;
    • Thomas, Laine;
    • Al-Khalidi, Hussein;
    • Alings, Marco;
    • Xavier, Dennis;
    • Ansell, Jack;
    • Goto, Shinya;
    • Ruzyllo, Witold;
    • Rosenqvist, Mårten;
    • Verheugt, Freek W. A.;
    • Jun Zhu;
    • Granger, Christopher B.;
    • Wallentin, Lars
    Publication type:
    Article
    8
    9

    Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.

    Published in:
    American Journal of Hematology, 2012, v. 87, p. S141, doi. 10.1002/ajh.23202
    By:
    • Kaatz, Scott;
    • Kouides, Peter A.;
    • Garcia, David A.;
    • Spyropolous, Alex C.;
    • Crowther, Mark;
    • Douketis, Jim D.;
    • Chan, Anthony K. C.;
    • James, Andra;
    • Moll, Stephan;
    • Ortel, Thomas L.;
    • Van Cott, Elizabeth M.;
    • Ansell, Jack
    Publication type:
    Article
    10
    11
    12

    Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.

    Published in:
    Journal of the American Heart Association, 2018, v. 7, n. 18, p. 1, doi. 10.1161/JAHA.118.008928
    By:
    • Washam, Jeffrey B.;
    • Holmes, DaJuanicia N.;
    • Thomas, Laine E.;
    • Pokorney, Sean D.;
    • Hylek, Elaine M.;
    • Fonarow, Gregg C.;
    • Mahaffey, Kenneth W.;
    • Gersh, Bernard J.;
    • Kowey, Peter R.;
    • Ansell, Jack E.;
    • Go, Alan S.;
    • Reiffel, James A.;
    • Freeman, James V.;
    • Singer, Daniel E.;
    • Naccarelli, Gerald;
    • Blanco, Rosalia;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.
    Publication type:
    Article
    13
    14

    Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

    Published in:
    2018
    By:
    • Steinberg, Benjamin A.;
    • Shrader, Peter;
    • Pieper, Karen;
    • Thomas, Laine;
    • Allen, Larry A.;
    • Ansell, Jack;
    • Chan, Paul S.;
    • Ezekowitz, Michael D.;
    • Fonarow, Gregg C.;
    • Freeman, James V.;
    • Gersh, Bernard J.;
    • Kowey, Peter R.;
    • Mahaffey, Kenneth W.;
    • Naccarelli, Gerald V.;
    • Reiffel, James A.;
    • Singer, Daniel E.;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.;
    • the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators;
    • Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators
    Publication type:
    journal article
    15

    Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).

    Published in:
    Journal of the American Heart Association, 2017, v. 6, n. 12, p. 1, doi. 10.1161/JAHA.117.006475
    By:
    • Thomas, Kevin L.;
    • Jackson II, Larry R.;
    • Shrader, Peter;
    • Ansell, Jack;
    • Fonarow, Gregg C.;
    • Gersh, Bernard;
    • Kowey, Peter R.;
    • Mahaffey, Kenneth W.;
    • Singer, Daniel E.;
    • Thomas, Laine;
    • Piccini, Jonathan P.;
    • Peterson, Eric D.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Comment on: 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.

    Published in:
    Journal of the American Geriatrics Society, 2023, v. 71, n. 12, p. 3951, doi. 10.1111/jgs.18579
    By:
    • Burnett, Allison E.;
    • Barnes, Geoffrey D.;
    • Allen, Arthur L.;
    • Ansell, Jack;
    • Blumenstein, Marilyn;
    • Connors, Jean M.;
    • Dager, William E.;
    • Kaatz, Scott;
    • May, Jori E.;
    • Nemeth, Ronni;
    • O'Connor, Carlee;
    • Ragheb, Bishoy;
    • Rajasekhar, Anita;
    • Sardo, Laurie;
    • Siegal, Deborah M.;
    • Van Beek, Andrea
    Publication type:
    Article
    23
    24

    Preface.

    Published in:
    Journal of Thrombosis & Thrombolysis, 1998, v. 5, p. 5, doi. 10.1023/A:1013253601022
    By:
    • Ansell, Jack
    Publication type:
    Article
    25
    26

    Preface.

    Published in:
    1995
    By:
    • Ansell, Jack
    Publication type:
    Editorial
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.

    Published in:
    Journal of Thrombosis & Thrombolysis, 2022, v. 54, n. 2, p. 197, doi. 10.1007/s11239-022-02643-3
    By:
    • Barnes, Geoffrey D;
    • Burnett, Allison;
    • Allen, Arthur;
    • Ansell, Jack;
    • Blumenstein, Marilyn;
    • Clark, Nathan P;
    • Crowther, Mark;
    • Dager, William E;
    • Deitelzweig, Steven B.;
    • Ellsworth, Stacy;
    • Garcia, David;
    • Kaatz, Scott;
    • Raffini, Leslie;
    • Rajasekhar, Anita;
    • Beek, Andrea Van;
    • Minichiello, Tracy
    Publication type:
    Article
    36

    Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

    Published in:
    Journal of Thrombosis & Thrombolysis, 2018, v. 46, n. 4, p. 435, doi. 10.1007/s11239-018-1715-1
    By:
    • Jackson, Larry R.;
    • Kim, Sunghee;
    • Shrader, Peter;
    • Blanco, Rosalia;
    • Thomas, Laine;
    • Ezekowitz, Michael D.;
    • Ansell, Jack;
    • Fonarow, Gregg C.;
    • Gersh, Bernard J.;
    • Go, Alan S.;
    • Kowey, Peter R.;
    • Mahaffey, Kenneth W.;
    • Hylek, Elaine M.;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Preface.

    Published in:
    2008
    By:
    • Ansell, Jack
    Publication type:
    Editorial
    49
    50